Gena Wang analyst BARCLAYS

Currently out of the existing stock ratings of Gena Wang, 209 are a BUY (67.86%), 66 are a HOLD (21.43%), 33 are a SELL (10.71%).

Gena Wang

Work Performance Price Targets & Ratings Chart

Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 68.16% that have a potential upside of 25.55% achieved within 163 days.

Gena Wang’s has documented 599 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Energy, Technology sectors.

Most recent stock forecast was given on CYTK, Cytokinetics at 02-Sep-2025.

Wall Street Analyst Gena Wang

Analyst best performing recommendations are on SMCI (SUPER MICRO COMPUTER).
The best stock recommendation documented was for SMCI (SUPER MICRO COMPUTER) at 2/13/2024. The price target of $961 was fulfilled within 2 days with a profit of $169.51 (21.42%) receiving and performance score of 107.08.

Average potential price target upside

ALNY Alnylam Pharmaceuticals ARCT Arcturus Therapeutics Holdings AVRO AVROBIO BCRX BioCryst Pharmaceuticals BEAM Beam Therapeutics  BLUE Bluebird bio CLVS Clovis Oncology CRSP Crispr Therapeutics AG DBTX Decibel Therapeutics EDIT Editas Medicine IONS Ionis Pharmaceuticals KOD Kodiak Sciences LOGC LogicBio Therapeutics NTLA Intellia Therapeutics PBYI Puma Biotechnology PGNX Progenics Pharmaceuticals PTCT PTC Therapeutics RARE Ultragenyx RGNX Regenxbio SGEN Seagen SGMO Sangamo Therapeutics SGTX Sigilon Therapeutics  SLDB Solid Biosciences LLC SRPT Sarepta Therapeutics VIR Vir Biotechnology BMRN Biomarin Pharmaceutical ONCE Spark Therapeutics VRTX Vertex Pharmaceuticals CLLS Cellectis SA MGTX MeiraGTx Holdings PLC MRNA Moderna ORTX Orchard Therapeutics PLC ZYME Zymeworks Common Stock IDRA Idera Pharmaceuticals LEGN Legend Biotech Corp ABEO Abeona Therapeutics DTIL Precision BioSciences HALO Halozyme Therapeutics MRTX Mirati Ther RTRX Travere Therapeutics SUN Sunoco LP JBL Jabil Circuit SMCI Super Micro Computer CYTK Cytokinetics EIDX Eidos Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$500

$43.65 (9.57%)

$330

18 days ago
(18-Sep-2025)

23/24 (95.83%)

$46.44 (10.24%)

209

Buy

$520

$63.65 (13.95%)

$359

20 days ago
(16-Sep-2025)

10/11 (90.91%)

$68.27 (15.11%)

142

Buy

$566

$109.65 (24.03%)

$370

21 days ago
(15-Sep-2025)

8/10 (80%)

$104.76 (22.71%)

289

Buy

$515.05

$58.7 (12.86%)

$260

26 days ago
(10-Sep-2025)

2/3 (66.67%)

$46.47 (9.92%)

137

Buy

$470

$13.65 (2.99%)

$360

29 days ago
(07-Sep-2025)

6/6 (100%)

$14.97 (3.29%)

136

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Gena Wang is most bullish on?

Potential upside of $14.03 has been obtained for CYTK (CYTOKINETICS)

Which stock is Gena Wang is most reserved on?

Potential downside of -$19.37 has been obtained for PTCT (PTC THERAPEUTICS)

What Year was the first public recommendation made by Gena Wang?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?